Defunct Company
Total Trials
2
As Lead Sponsor
0
As Collaborator
Total Enrollment
48
NCT04592549
Study of Monoclonal Antibody Cocktail Being Tested for the Prevention of COVID-19
Phase: Phase 1
Role: Collaborator
Start: Dec 4, 2020
Completion: Oct 6, 2023
NCT05142527
Study to Evaluate the Safety and Efficacy of a Monoclonal Antibody Cocktail for the Prevention of COVID-19
Phase: Phase 2/3
Start: Jan 31, 2023
Completion: Apr 30, 2024